Ilaprazole: all 25 studies that test it
Page 1 of 1. Open to participants first (1), then studies with results posted, then the rest; newest registration first within each.
- Study to Evaluate the Efficacy and Safety of Ilaprazole 10 mg in Prevention NSAIDs Associated Peptic UlcerRecruitingNCT06284876Phase 3
- Study to Evaluate Pharmacokinetic and Pharmacodynamic Drug Interactions and Safety of IY-NS250 and IY-NT-SRCompletedNCT06725992Phase 1
- A Multi-center, Double-blinding, Parallel and Positive-controlled Phase III Clinical Trial for Efficacy and Safety Evaluation of Ilaprazole Sodium for Injection on Prevention of Stress Ulcer BleedingCompletedNCT05841394Phase 3
- Study to Evaluate the Safety and the Pharmacokinetics of IY-NT-TStatus unknownNCT05617651Phase 1
- Study to Evaluate Pharmacokinetic Drug Interactions and Safety of Ilaprazole and AceclofenacCompletedNCT05558150Phase 1
- Study to Evaluate the Safety and the Pharmacokinetics of IY-NT-TCompletedNCT05509543Phase 1
- Study to Evaluate Pharmacokinetic Drug Interactions and Safety of Naproxen, Aceclofenac, Celecoxib and IlaprazoleCompletedNCT05237297Phase 1
- Phase III Study to Evaluate Safety and Efficacy of Ilaprazole in Patients With NERDCompletedNCT03444883Phase 3
- Ilaprazole for the Treatment and Prevention of Peptic Ulcer Bleeding in Chinese PatientsCompletedNCT03362281Phase 3
- IIaprazole for the Treatment and Prevention of Peptic Ulcer Bleeding in Chinese PatientsCompletedNCT03362268Phase 2
- Study to Evaluate Pharmacokinetic Drug Interactions and Safety of Clarithromycin, Amoxicillin and IlaprazoleCompletedNCT02998437Phase 1
- Efficacy and Safety of 1-week Triple Therapy With Ilaprazole for the Eradication of Helicobacter PyloriCompletedNCT02873065Phase 4
- Ilaprazole for the Treatment of Gastroesophageal Reflux Disease (GERD) in Chinese PatientsCompletedNCT02860624Phase 3
- Ilaprazole for the Treatment of Duodenal Ulcer in Chinese PatientsCompletedNCT02847455Phase 2/3
- The Prospective Study on the Effect of Ilaprazole in Non-erosive Reflux Disease Patients; Focused on Histologic Findings and Inflammatory BiomarkerCompletedNCT02666976Phase 4
- Effects of Ilaprazole on Ulcer Healing Rate and Prevention of Gastrointestinal Bleeding in the Patients Undergone ESD.CompletedNCT02638584Phase 4
- Dual Therapy With High Doses of Ilaprazole and Amoxicillin for Helicobacter Pylori InfectionCompletedNCT02401477Phase 4
- Efficacy/Safety Study as H. Pylori Eradication of Triple Therapy for 7 Days TreatmentCompletedNCT02084420Phase 3
- Study to Evaluate the Pharmacokinetics, Pharmacodynamics and SafetyCompletedNCT01820143Phase 1
- Pharmacokinetic/Pharmacodynamic Study of Ilaprazole to Evaluate the Effect of CYP Genetic PolymorphismCompletedNCT01688544Phase 1
- Efficacy Study of Ilaprazole to Treat Erosive EsophgitisCompletedNCT01509261Phase 3
- Ilaprazole for the Treatment of Gastroesophageal Reflux Disease (GERD) in Chinese PatientsStatus unknownNCT01107938Phase 2
- Ilaprazole for the Treatment of Duodenal Ulcer in Chinese Patients (Phase 2)CompletedNCT00953381Phase 2
- Ilaprazole for the Treatment of Duodenal Ulcer in Chinese Patients (Phase 3)CompletedNCT00952978Phase 3
- Safety and Efficacy of Ilaprazole 5, 20 and 40 mg QD and Lansoprazole 30 mg QD on Healing of Erosive EsophagitisCompletedNCT00471094Phase 2